← FDA Drug Approvals (Drugs@FDA)

ESBRIET

NDA · New Drug Application · Sponsor: LEGACY PHARMA · Approved 2014-10-15

Drug application

FDA Application #

NDA022535

Application type

New Drug Application

Brand name

ESBRIET

Generic name

Pirfenidone

Active ingredients

PIRFENIDONE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

LEGACY PHARMA

First approval

2014-10-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown